Book Of Likes Faces

Additional to the paragraph before there is some more information about what is going on respecting the Pandemic:
The companies Pfizer and BioNTech words were: "We share the urgency to expand the authorization of our vaccine to use in younger populations and are encouraged by the clinical trial data from adolescents between the ages of 12 and 15,” Bourla said in a press release.
The trial enrolled 2,260 participants in the United States. There were 18 confirmed Covid-19 infections observed in the placebo group and no confirmed infections in the group that received the vaccine, the company said. That resulted in a vaccine efficacy of 100%, it said, adding that the shot was also well-tolerated, with side effects generally consistent with those seen in adults.

The vaccine makers Pfizer and BioNTech are saying that their Covid vaccine is 100% effective in kids ages 12 to 15.
( effective in preventing Covid-19 in children ages 12 to 15 years old).
In between the laboratory company Pfizer has immediate plans to submit the new vaccine data to the FDA “as soon as possible,” CEO Albert Bourla said.
Kids in the age group could be eligible for the vaccine before the new school year.

Last Wednesday Pfizer said its Covid-19 vaccine was 100% effective in a study of adolescents ages 12 to 15, encouraging results that could clear the shots for use in middle school students before school starts this fall (these words will make parents more relief about their kids being exposed to the virus).

Pfizer CEO Albert Bourla said the company plans to submit the new data on the vaccine, which is developed in partnership with German drug-maker BioNTech, to the Food and Drug Administration and other regulators “as soon as possible,” with the hope that kids in the age group will be able to get vaccinated before the next school year.